Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 16:0/18:2/20:5)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004110 AN006813 Lipidomics characterization from plasma VLDL fractions isolated from human PNPLA3 wild type and human PNPLA3(I148M) knock in mice. Blood Mouse Liver disease Amgen LC-MS
ST002303 AN003763 Fitm2 is required for ER homeostasis and normal function of murine liver Liver Mouse Harvard School of Public Health LC-MS
ST001313 AN002186 Lipid expression in serum after early life exposure to an endocrine disruptor and a Western Diet at 240 days postnatal (part-IV) Blood Rat Environmental exposure Baylor College of Medicine LC-MS
ST001312 AN002184 Lipid expression in serum after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-III) Blood Rat Environmental exposure Baylor College of Medicine LC-MS
ST001311 AN002182 Lipid expression in liver after early lifer exposure to an endocrine disruptor at 70 days postnatal in the liver (part-II) Liver Rat Environmental exposure Baylor College of Medicine LC-MS
ST000077 AN000123 Metabolite changes associated with methionine stress sensitivity of cancer (CSH QTOF MS analysis) Breast cancer cells Human Cancer University of California, Davis LC-MS
ST000075 AN000119 Combined Metabolomics and Lipidomics of Type 1 Diabetes (QTOF) Blood Mouse Diabetes University of California, Davis LC-MS
  logo